Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ocugen Inc (NQ: OCGN )

0.9222 UNCHANGED
Streaming Delayed Price Updated: 11:57 AM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
32 Stocks Moving In Monday's Mid-Day Session
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 99.7% to $14.42 after jumping 38% on Friday. Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 30.5% to $64.... 
Via Benzinga
OCGN Stock: The Big Study News Shooting Ocugen Shares Higher Today
Ocugen (OCGN) stock is soaring on Monday after announcing positive data concerning its Covaxin vaccine candidate for the novel coronavirus. 
Via InvestorPlace
Why Ocugen Shares Are Trading Higher Today
Ocugen (NASDAQ: OCGN) shares are trading higher after the company announced studies showing COVAXIN is potentially effective against three key variants of SARS-CoV-2. In the... 
Via Benzinga
Is Now The Time To Buy Stock In Ocugen, Tilray Or Nio?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
Why Ocugen's Stock is Down During Today's Session
Ocugen's Stock Price And Volume Action Ocugen's (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers BioVie (NASDAQ:BIVI) shares increased by 12.96% to $19.78 during Monday's pre-market session. The company's market cap stands at $275.2 million. Ocugen (... 
Via Benzinga
Ocugen Shares Gain After Its Partner's COVID-19 Vaccine Shows Effectiveness Against Multiple Variants
Ocugen Inc (NASDAQ: OCGN) has announced that in a new study, COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2.... 
Via Benzinga
Exposures COVID-19
If You Have Ocugen Stock, Now’s the Time to Take Profits
The U.S. vaccine rollout narrative doesn’t look great for OCGN stock, so profit-taking should be considered. 
Via InvestorPlace
Exposures COVID-19
Despite Covaxin News, Ocugen Stock Remains a Long-Shot for US Use
Yet, there's little to indicate it will obtain FDA approval. In addition, there's plenty suggesting that the U.S., already oversupplied when it comes to vaccines, has little need for Covaxin. In short,... 
Via InvestorPlace
Exposures COVID-19 Product Safety
3 Popular Reddit Biotech Stocks That You Should Avoid
We think speculative Reddit biotech stocks Ocugen, Inc. (OCGN), Humanigen Inc. (HGEN), and 180 Life Sciences Corp. (ATNF) should be avoided at all costs given questions about their prospects or ability... 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 30.17% to $1.42 during Friday's regular session. As of 12:31 EST, this security is trading at a volume of... 
Via Benzinga
Better Robinhood Stock: Ocugen or Aphria?
Both have delivered impressive returns this year. 
Via The Motley Fool
Cramer Weighs In On Coinbase, Kellogg And More
Jim Cramer said on CNBC's "Mad Money Lightning Round" that he has always felt that Ocugen Inc (NASDAQ: OCGN) is a great spec, but it's a heavily shorted stock... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Galera Therapeutics (NASDAQ:GRTX) stock moved upwards by 23.75% to $8.18 during Wednesday's after-market session. Today's trading volume for this security ended up... 
Via Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
The Reasons to Avoid OCGN Stock Keep Piling Up
Ocugen faces as tough a road to U.S. Covaxin sales as ever 
Via InvestorPlace
Exposures Product Safety
Here's the Biggest Risk With Buying Ocugen Stock Right Now
It comes down to timing. 
Via The Motley Fool
Exposures COVID-19
A Couple Of Shots in the Arm for Ocugen Stock
Off and on the price chart, OCGN stock is setting itself up for big things that should have the attention of bullish investors. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million... 
Via Benzinga
What's Going On With Ocugen Stock And Upstart Stock Today?
Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 6.82% at $10.80 after the company reported a common stock offering of 10 million shares. Ocugen is a clinical-stage... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market session. The company's market cap stands at $661.8... 
Via Benzinga
Is Ocugen a Buy?
This biotech obtained rights to sell a highly effective coronavirus vaccine in the U.S. Can it pull it off? 
Via The Motley Fool
Exposures COVID-19
If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing
In this crazy Reddit-driven stock market, it's still important to understand why OCGN stock is hot. And why it's dangerous. 
Via InvestorPlace
Why Ocugen's Stock Is Surging Today
Ocugen, Inc. (NASDAQ: OCGN) shares are trading higher after the White House announced it would immediately make available specific raw materials needed by India to make COVID-19... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
Ocugen Stock Is Tethered To Its Covid-19 Vaccine
OCGN stock looks to have bottomed and is once againt moving higher, raising questions of whther investors should now take a position. 
Via InvestorPlace
Exposures COVID-19
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Reviva Pharmaceuticals Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.08% to 34,015.96 while the NASDAQ rose 0.83% to 14,133.38. The S&P also rose, gaining 0.24% to 4,190.04. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
Mid-Day Market Update: Proofpoint Jumps Following Acquisition News; Fortuna Silver Mines Shares Slide
Midway through trading Monday, the Dow traded up 0.14% to 34,092.01 while the NASDAQ rose 0.59% to 14,099.52. The S&P also rose, gaining 0.31% to 4,193.06. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
38 Stocks Moving In Monday's Mid-Day Session
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.